With the successful audit by the local authorities, our new plant has established itself as an important site for the manufacture of pharmaceutical drugs in clinical phases and commercial drugs. This step marks a significant milestone on our company’s path to establishing itself as a reliable GMP-certified company and makes an important contribution to safeguarding medical care in Germany and Europe. “With the successful audit, we are now in a position to serve our customers with state-of-the-art technologies and processes in accordance with the latest regulatory requirements. Our new plant sets standards in the field of aseptic manufacturing,” explains Thorsten Häfner, Vice President Business Development and authorized officer of the company.
